Antoine Danchin ©
Cyclic AMP is ubiquitous in regulation of enzyme
activities and/or gene expression in all kingdoms of life except
Archaea. This accounts for the interest displayed in its mode
of synthesis, and the vast amount of literature devoted to the
enzymes that produce cAMP, the adenylyl cyclases (ACs, often
known previously under the name adenylate cyclase, or adenyl
cyclase, ATP pyrophosphate-lyase, 3',5'-cyclic AMP synthetase EC
4.6.1.1). These enzyme, which perform synthesis of cAMP from
ATP, yielding pyrophosphate as a by-product, can be classified
into five different classes according to their common features.
Namely, we count cyclases related to enterobacterial adenylate
cyclases, toxic adenylate cyclases isolated from bacterial pathogens,
a large and probably ancient class that comprises cyclases from
eukaryotes and prokaryotes and is strongly related to guanylyl
cyclases, a fourth class, presently known only from a few bacterial
species, Aeromonas hydrophila and Yersinia pestis for
example, that appears to differ entirely from all other classes
and finally a cyclase present in the anaerobe Prevotella
ruminicola. This indicates a remarkable case of convergent
evolution. Two review articles have been written to delineate
the main features of the corresponding classification (1993 , 1994 ),
that is now used as the reference classification of adenylyl
cyclases. Guanylyl cyclases belong to the cyclases class III.
The first complete adenylate cyclase (formerly
adenylate cyclase) gene was cloned and sequenced from
the model bacterium Escherichia coli. It
is located near the origin of replication of the organism,
in an environment involved in iron metabolism. Molecular genetic
and biochemical studies demonstrated that E. coli adenylyl
cyclase is made of two domains. The catalytic domain is
NH2-terminal whereas the glucose sensitive regulatory
domain is COOH-terminal. Its function is still enigmatic at
the end of year 2004. Work performed on other Enterobacteria
such as Erwinia
chrysanthemi, Proteus mirabilis, Salmonella
typhimurium, Yersinia intermedia and Yersinia
pestis demonstrated that both
the genes environment and the proteins were similar in
size and overall organization to the E. coli genes
and proteins at the corresponding locus, cyaA.
The downstream gene expressed in the opposite orientation, cyaY,
is involved in iron metabolism, it has an analog in Eukarya,
frataxin, and a defect is responsible for Friedreich ataxia
in humans. Analysis of the cyaA gene from other bacterial
species, related to Enterobacteria but distinct from them,
using complementation of appropriate cyaA defective
strains of E. coli (and more recently by direct sequencing
of whole genomes) revealed that the genes from many other bacteria,
in particular Aeromonas caviae, Aeromonas hydrophila, Haemophilus
influenzae, Pasteurella
multocida, Vibrio cholerae direct synthesis
of a protein structurally
and phylogenetically related to the E. coli cyclase.
The gene is absent from many Bacteria, including Gamma-proteobacteria
such as Xanthomonas campestris, or Pseudoalteromonas
haloplanktis.
No long stretch of hydrophobic amino-acid
residues in the protein sequence suggested an explanation for
the known membrane bound localisation of the proteins. In all
cases the proteins are very rich in cysteine residues, an uncommon
feature for proteins located in the cytoplasm or at the cytoplasmic
border of the membrane. This might account for the extreme
difficulty in purifying the enzyme. In addition, the proteins
are also rich in histidine residues. This could indicate that
metal ions take part in the folding and/or activity of the
polypeptide chain, but no experimental data support this hypothesis.
Finally, the protein is made of two functionally well-defined
domains. Comparison of the catalytic domain polypeptide sequence
of the E. coli enzyme with known sequences present
in the protein data libraries did not reveal significant identities
with other known proteins. The catalytic domain sequence is
ca 420 residues, experimentally identified. Amino acid residue
differences in the Erwinia chrysanthemi enzyme when
compared to its counterparts, are often due to the presence
of complementary charged residue in place of neutral ones.
This suggests that ionic interactions (including salt bridges)
are more often present and stabilise the protein at the lower
growth temperature of this bacterium. This observation might
be helpful when trying to understand the tertiary structure
of the protein, not yet deciphered.
The carboxy-terminal domain of the protein
is involved in regulation of the enzyme activity, in particular
in its inhibition in the presence of glucose. A component of
the phosphorylation cascade mediating import of glucose in
the cell, enzyme IIAGlc has been proven to be involved
in regulation, in a way not yet understood. An aspartate
residue (D414 in the E. coli enzyme), appears to be
involved in the process, in an unknown way. A reflection
on the structure of the enzyme suggests that tonic inhibition
of the catalytic domain by the regulatory domain could be relieved
by phosphorylation (or methylation) of this residue (modification
has never been demonstrated, however).
Whooping cough is caused by the Gram negative
bacterium Bordetella pertussis, that secretes into
the medium many toxic proteins, including an adenylate cyclase.
In 1980, it was discovered that AC
is activated by a host protein, calmodulin, that is not
known to occur in bacteria. Two years later Leppla demonstrated
that another toxic AC, secreted by a Gram positive bacterium, Bacillus
anthracis, the etiological agent of the now infamous anthrax,
was also activated by host calmodulin. These observations stimulated
intense efforts, but in spite of numerous attempts, it took
several years before the cyaA genes from either organisms
could be cloned. However a simple idea, predating its generalisation
under the name of "double hybrid technique", in vivo
complementation by a plasmid encoding an activator of the function
(in this case, calmodulin), permitted in 1988, the cloning
and sequencing of AC genes coding for the calmodulin-dependent
cyclases (1988a, 1988b).
Cloning of a toxin from such a dangerous organism triggered ethical
reflections that were only taken into account seriously many
years later.
Bordetella pertussis AC is synthesized
as a large bifunctional polypeptide of 1706 amino-acid residues.
Different authors had however published various low values
for the purified protein molecular weight (from 43 to 70 kDa).
This fluctuation in biochemical data was understood when it
was demonstrated that the N-terminal segment of the protein
(400 residues) displays calmodulin-activated AC activity, while
the rest of the molecule was responsible for the hemolytic
activity and the secretion
of the toxin in the external medium. Sequencing, molecular
genetic and physiological studies indicated that the AC domain
was fused to a polypeptide similar to the polypeptide chain
of E. coli hemolysin toxin. The name cyclolysin was
therefore coined for the toxic adenylate cyclase from B.
pertussis. The AC of B. anthracis has been named
after the symptom it triggers in the infected host, edema factor
(EF). It is encoded in a plasmid, together with another toxin,
the lethal factor (LF) and a carrier protein, the protective
antigen (PA), which is necessary for internalisation of both
EF and LF into host target cells. The AC (EF) protein, 800
amino-acid residues long, comprises four regions of different
function. The first region is a signal peptide, permitting
secretion of the protein. The second region corresponds to
the domain permitting binding with PA. The third region encodes
the adenylate cyclase function. It is followed by a region of
unknown function. These toxic ACs have been subjected to a
most thorough biochemical analysis. The enzyme from B.
anthracis has been crystallized
and its 3D structure determined.
In spite of several attempts to isolate
other members of this class we know only three examples of
such proteins, isolated from extremely distant bacteria, a
Gram positive one and two Gram negative (the AC from B.
bronchiseptica is very similar to the B. pertussis enzyme).
Comparison between the catalytic region of the B. pertussis and B.
anthracis ACs identified four conserved regions that are
involved in catalysis, calmodulin binding and activation. The
first region comprises a Walker-type peptide, G----G(A)KS,
similar to the nucleotide binding region found in many ATP
or GTP binding proteins. It was therefore proposed to be part
of the catalytic site. In vitro mutagenesis substantiated this
interpretation. A second region, PLTADID, displaying some similarity
with 6-phosphofructokinase, was also shown to be involved in
catalysis, and it was proposed that the aspartate residues
present in this region are involved in ribose and magnesium-phosphate
binding. However, in spite of strong conservation, the first
proline residue does not seem very important since it could
be replaced by a leucine residue without any measurable influence
on the activity or calmodulin activation of the wild type enzyme.
Although many calmodulin-dependent enzymes
have been identified, the mechanism of activation by calmodulin
is still poorly understood. In several cases, limited proteolysis
released active calmodulin-independent forms of enzymes. Accordingly,
it was proposed that the calmodulin-binding domain of these
enzymes blocks the access of substrates to the active site
and that activation results because following binding of calmodulin
an inhibitory domain is removed. The most original feature
of the B. pertussis protein is that it can be split
into two separate domains that can recover most of the initial
activity when put together. This observation together with
analysis of mutants in the region conserved between the B.
anthracis and B. pertussis enzymes, indicates
that the proteins may form a catalytic center from the cooperation
of two halves, the function of calmodulin being to trigger
the appropriate conformational move necessary for the formation
of an active catalytic center.
Remarkably, class II adenylate cyclases also
exist in Yersinia species, as well as in Pseudomonas
aeruginosa. However their mechanism of activation has
not yet been unraveled, while it is known that calmodulin is
not an activator.
adenylate cyclases from multicellular eukaryotes
have long remained elusive, because the purification of the
corresponding catalytic subunit is extremely difficult. Following
intense work all over the world they have however been the
first ACs to be crystallized and analyzed by X-rays diffraction
studies. The activity of these enzyme is subject to a complex
regulatory pattern, in particular by GTP
binding proteins. This will not be discussed here. Class
III enzymes have first been discovered in yeast, but, for convenience,
we shall start with the Bacterial enzymes. Among recent discoveries
is the regulation of some of the soluble enzymes by bicarbonate.
Class III ACs forms a very diverse collection
in eubacteria, both in length and in regulation. Gram positive
bacteria such as Corynebacterium liquefaciens secrete
a large quantity of cAMP. This is due to a very active class
III AC, requiring the presence of pyruvate for activation. Streptomyces
coelicolor synthesizes a much less active AC that is involved
in aeromycelium formation. Gram-negative bacteria such as Rhizobium
meliloti synthesize several different ACs (disruption
of both genes at the same time did not alter cAMP production,
suggesting the presence of more ACs). The Gram negative sliding
bacterium (myxobacteria), exhibiting an elaborated differentiation
pattern, Stigmatella aurantiaca, harboured at least
two AC genes, each of them corresponding to class III enzymes.
Another myxobacterium, Myxococcus xanthus also has
several such enzymes. These latter enzymes have been partially
purified and shown to be inhibited by adenosine, as are the
mammalian enzymes (see below). They comprise two domains, the
catalytic domain being carboxy-terminal and the regulatory
domain, a likely ion transporter in one case, and the phosphorylated
moiety of a 2-component regulatory system in the other case.
Many other Bacteria possess class III cyclases, in particular
cyanobacteria. These enzyme generally comprise two domains,
the catalytic domain being carboxy-terminal. There is no indication
that they must oligomerize to be active. A remarkable situation
is presented with R. meliloti and its many cyclases,
while Mycobacterium tuberculosis has probably as many
as 15 such enzymes. The product of gene Rv1625c in this organism
displays adenylate cyclase activity. The enzyme has been crystallized
and preliminary data allowed the authors to propose
a 3D structure.
Saccharomyces cerevisiae was the
first organism in which class III AC genes have been cloned
and sequenced. The enzyme is activated by the RAS gene product.
Two forms of the enzyme may exist, a long form containing repetitions
of a leucine rich motif that plays a regulatory role, whose
significance was recently substantiated and extended. It was
clear then that this eucaryotic AC was completely different
from the enterobacterial class, not only because of the sequence
difference in the catalytic center, but also because the organisation
of the gene was different: the catalytic domain is located
at the COOH-terminus in S. cerevisiae cyclase, whereas
it can be found at the NH2-terminus in E. coli. The
yeast enzyme remained the only instance of its class until
Garbers, Goeddel and coworkers recognized that the guanylyl
cyclase coding genes that had been cloned from several metazoans,
were derived from an ancestor in common with yeast AC. Another
member of class III was subsequently discovered by Young et
al. who cloned the AC gene from Schizosaccharomyces pombe by
hybridization using the catalytic domain gene sequence from S.
cerevisiae as a probe. Finally, the first higher eukaryote
AC gene isolated in Gilman's laboratory from bovine brain,
displayed features clearly reminiscent of this class. Since
then many other genes or cDNAs for ACs belonging to this class
have been isolated and sequenced from lower eukaryotes Saccharomyces
kluyveri, Trypanosoma brucei and T. equiperdum, Plasmodium
falciparum, Neurospora crassa, Dictyostelium
discoideum, where it is involved in differentiation.
Many class III ACs have been identified in
higher eukaryotes, in particular in vertebrates, but the most
thorough study is in mammals, where several types, differing
by their regulatory properties have been identified All are
regulated in more or less complex ways by G proteins. Mammalian
ACs have been informally grouped into nine types, according
to their tissue location and activity regulation. All but type
9 are activated by the diterpene forskolin, some are by protein
kinase C and/or other regulators. Type 1 enzymes were described
as calmodulin activated enzymes from brain, type 2 proteins
are found in brain, lung and other tissues, type 3 are abundant
in olfactory tissue, and the smaller type 4 enzymes are present
in testicular tissue. AC 1, 2 and 8 are positively regulated
by calcium/calmodulin, whereas types 5 and 6 are directly inhibited
by calcium. AC
2 and 4 are sensitive to multiple regualatory inputs proceeding
from diverse receptors. AC9 mRNA is found in rat brain. It
is particularly abundant in hippocampus, cerebellum, and neocortex.
It should be noted however that the classification into
types is somewhat arbitrary (note for instance that type 4
can also be calmodulin-activated). They all have overall similar
structure, with two phylogenetically related cytoplasmic domains
required for catalysis, connected by an integral membrane domain
and variable integral membrane domains at the NH2 terminus
of the protein. Among their many functions, their role in synaptic
plasticity and memory is particularly interesting, and will
certainly make ACs again extremely fashionable.
The widely spread origin of class III ACs
is reflected by the wide variation in their general organisation
and molecular weight. The smallest protein is the R. meliloti enzyme,
which appears to contain only a catalytic domain. Yet data
exist, suggesting that an upstream sequence may yield a much
longer protein having a complex regulatory pattern. The next
shortest protein, also a bacterial one, is the enzyme from C.
liquifaciens. The yeasts yield long proteins, as do higher
eukaryotes (except perhaps in the case of the testicular enzyme).
In all cases, the catalytic domain is located at the COOH-terminus.
The mammalian enzymes consist in twelve hydrophobic membrane-spannning
regions forming two distinct domains, and two cytoplasmic regions
which contains both variable and conserved regions, and, in
particular, two well-conserved domains that are responsible
for catalysis .
Comparison of the catalytic domains sequence
of the class III proteins showed that four amino-acid stretches,
(M/L/I/V)(M/L/I/V)F(A/T)(D/S)(L/I)–(N/D)(F/S), (I/V)KT–G(S/D)(A/S/T)(Y/F)M,
(M/L/I/V)(R/K)(M/L/I/V)G(M/L/I/V) (H/N)–(V/A)(V/A)(A/S)G,
and (W/Y/F)G(N/D/P)TVN–ASR(M/L/I/V) are strongly conserved.
Crystallisation of the catalytic core of the protein and determination
of its structure by X-rays diffraction showed that these regions
are part of the organisation of the structure. The crystal
structure gives the forskolin binding site, but unfortunately
not the nucleotide binding site. Further work involving co-crystals
with G-proteins unraveled the nature
of the substrate binding site. As a step towards understanding
evolution and function of class III cyclases, enzymes displaying
significant guanylyl
cyclase activity having evolved from an adenylate cyclase ancestor
were isolated. A single amino-acid residue change (GDTVN to
GDTIN), in the region of the fourth alpha-helix of the catalytic
core, altered the nucleotide specificity of the enzyme. This
corresponds to a pocket situated in a region of the protein
that is invoved in accomodation of the heterocyclic base.
Cyclic GMP is synthesized from GTP, yielding
pyrophosphate as a product, by the enzyme guanylyl cyclase
(guanylate cyclase, guanyl cyclase EC
4.6.1.2). CyclicGMP acts as an second messenger, activating
cGMP-dependent kinases and/or regulating cGMP-sensitive gated
ion channels. The role of cGMP as an intracellular messenger
in vascular smooth muscle relaxation and retinal photo-transduction
is well established. Garbers, Goeddel and coworkers found that
the catalytic centers of guanylyl cyclases were strongly related
to eukaryotic class III adenylate cyclases. Thus GCs form a
single class, in contrast to adenylate cyclases, but are of
at least two very different types, linked to the function of
the enzyme in the cell. Guanylyl cyclase is found both in the
soluble and particulate fraction of eukaryotic cells. The soluble
and plasma membrane-bound forms differ in structure, regulation,
biochemical and physico-chemical properties and constitute
two distinct families. The currently known plasma membrane-bound
forms (sensor-family) have been first identified as receptors
for small polypeptide hormones. This first type is a complex,
membrane bound, enzyme made of a receptor for specific hormones
coupled to a catalytic domain similar in sequence and structure
to the catalytic domain of class III adenylate cyclases.
Guanylyl cyclases in family I acts as sensors,
and are often receptors for hormones such as atrial natriuretic
peptide, involved in the control of osmotic pressure and sodium
excretion in mammals. The known guanylyl cyclase receptors
have been recognized as forming several subfamilies. Guanylyl
cyclases receptors from the sea-urchins recognize speract and
resact, which are small peptides that stimulate sperm motility
and metabolism. The receptors for natriuretic peptides (ANF)
exist in two forms that both synthesize cGMP: GC-A (also named
ANP-A), which seems specific to atrial natriuretic peptide
(ANP), and GC-B (or ANP-B) which are stimulated by brain natriuretic
peptide (BNP) than by ANP. There seem to be at least three
ANP receptors: two with GC activity (ANP-A and ANP-B) and one
(ANP-C) which is responsible for the clearance of ANP from
the circulation without a role in signal transduction. Intestine
cells contain the receptor for the Escherichia coli heat-stable
enterotoxin (GC-C). The endogenous ligand for this intestinal
receptor seems to be a small peptide called guanylin. Odorant
information is encoded by a series of intracellular signal
transduction events thought to be mediated primarily by the
second messenger cAMP. But a subset of olfactory neurons expresses
a cGMP-stimulated phosphodiesterase (PDE2) as well as a GC
of the receptor type (GC-D), demonstrating that cGMP has an
important regulatory function in olfactory signalling. Finally,
retinal GCs (often named retGC) exist in at least two forms,
GC-E and GC-F. They play a specific functional role in the
rods and/or cones of photoreceptors triggering a protein phosphorylation
cascade. It consists of an apparent extracellular domain linked
by a single transmembrane segment to an intracellular domain.
It is coupled to GC activating protein-2, which is a Ca2+-binding
protein that activates RetGC-1 in a Ca2+-sensitive manner.
It is not known whether retGC acts as receptor, but its structure
is similar to that of the other plasma membrane-bound GCs.
The organisation of all these GCs is similar:
they have a N-terminal extracellular domain which acts as the
ligand binding region, then a transmembrane domain, followed
by a large cytoplasmic C-terminal region that can be subdivided
into two domains: a protein kinase-like domain that is important
for controlling the protein phosphorylation cascade linked
to the specific signal recognized by the cognate GC, and a
GC catalytic domain.
In contrast, the second family of GCs is
cytoplasmic and soluble (hence the shorthand for soluble GC,
sGC). It controls a completely different set of regulations.
These cytoplasmic GCs form always heterodimers. The two subunits,
alpha and beta are proteins which, although different in length
(from 70 to 82 KDa) and sequence are highly related. Two forms
of beta subunits are currently known: beta-1 which seems to
be expressed in lung and brain, and beta-2 which is more abundant
in kidney and liver. The most fascinating feature of these
subunits is that they bind a heme prosthetic group. Upon binding
of nitric oxide the sGC catalytic activity is stimulated, generating
the intracellular signaling molecule cGMP. Discovered in 1987,
NO is a signal transduction molecule, and its importance has
been stressed by its role in blood circulation and cardiac
muscle functioning. Carbon monoxide (CO) (which
has been found in bacteria but does not have a clear cut
function as yet) also seems to play a role similar to that
of NO. Fifteen conserved cysteine residues on sGC have been
mutated to serine by in vitro site-directed mutagenesis. All
of the resulting recombinant enzymes were able to synthesize
cGMP, demonstrating that they are not directly involved in
catalysis, but mutation of two cysteines located in the N-terminal,
putative heme-binding region of the beta subunit yielded proteins
that were insensitive to NO, and lost their heme prosthetic
group. In contrast mutation of the corresponding cysteines
on the alpha subunit did not alter NO responsiveness, indicating
that heme-binding is probably a specific feature of the N-terminal
domain of the beta subunit.
In general, gene organisation revealed conservation
in both types of enzymes, of the localization of at least one
catalytic domain in the carboxy-terminal part of the protein,
coupled to a variety (in length and in sequence) of amino-terminal
parts. The membrane and cytoplasmic forms of GCs share a conserved
domain which is fundamental for the catalytic activity of the
enzyme. A similar domain is also found twice in the different
forms of membrane-bound class-III adenylate cyclases from mammals,
slime mold or Drosophila. A polypeptide consensus
pattern detects both domains of class-III ACs as well as GCs:
G-V-[LIVM]-x(0,1)-G-x(5)-[FY]-x-[LIVM]-[FYW]-[GS]-[DNTHKW]-[DNT]-[IV]-[DNTA]-x(5)-[DE].
The common origin between adenylate cyclases
and GCs, witnessed by the apparent facility with which it was
possible to build up a purine nucleoside triphosphate cyclase
of broad specificity, might be relevant to phylogeny of the
catalytic center of class III enzymes. This similarity suggested
the existence of an ancestral purine nucleotide triphosphate
cyclase as a precursor. As a consequence of this interpretation
of sequence data, one may wonder whether evolution has not
permitted the existence of some interlock between both nucleotides
syntheses, a given cyclase being triggered, under appropriate
regulatory conditions, to synthesise cAMP or cGMP alternatively.
This could have been used in cyclic nucleotide-mediated controls
existing in eukaryotes, and explain to the older observation
that, in some cases at least, cAMP and cGMP concentration was
varying in opposite way.
Three classes of non structurally related ACs
poses already a challenging problem. It came out as a surprise,
therefore, that Aeromonas
hydrophila species synthesized another enzyme (a very
small cyclase of 193 residues), that has an optimal temperature
for activity of 65°C, and that was at least ten times more
active than the class I AC present in the same organism. No function
has yet been discovered for this protein. It has been found in
various isolates of A. hydrophila. There has been one
report of the presence of cAMP in Archaea, but this was later
proven to be due to an artifact of the growth culture. It was
therefore interesting to see that the sequence of AC from A.
hydrophila was significantly similar to a gene product of Methanococcus
jannaschii. The gene was expressed in E. coli,
where it is toxic, but did not restore cAMP synthesis. Therefore
nothing is yet known about the nature of ACs, if they exist,
in Archaea, but we may expect that, at some point they might
be discovered, and that they would belong to this new class.
Interestingly, genome studies revealed that Yersinia species
possess a counterpart of the A. hydrophila enzyme. Even
more interestingly, sequence comparisons reveal that this class
of proteins is related to metabolism of Thiamine-triphosphate,
a new elusive phosphoryl donor that may have predated separation
between Bacteria, Eukarya and Archaea, and may have an important
role in enzyme regulation, that is still almost entirely enigmatic.
The 3D
structure of the protein from Y. pestis revealed
a novel fold, that spans the three domains of life.
Cotta
and coworkers found that ruminal bacteria Prevotella
ruminicola D31d produced detectable concentrations of
cAMP. The gene for adenylate cyclase was cloned and expressed
in a cyaA mutant of E. coli. The cloned P.
ruminicola D31d gene was able to complement the cyaA mutation
and permitted fermentation of lactose on MacConkey Lactose
agar plates. Production of cyclic AMP in the E. coli clone
was confirmed by radioimmunoassay. The 67-kDa protein was
novel in that no amino-acid similarity was observed with
other adenylate cyclases from Eukarya, Archaea or Bacteria.
This is the first example of an adenylate cyclase gene identified
from an anaerobic bacterium, stressing again the evolution
by convergence of synthesis of the important mediator, cAMP.
The study of cellulose synthesis by Bacteria revealed
that a novel second messenger molecule, bis-(3'5')-cyclic di-GMP
(c-diGMP), is extensively used by bacteria to control multicellular
behavior, antagonistically controlling motility and cell adhesion.
c-diGMP results from the condensation of two GTP molecules into
the cyclic compound, in a reaction that is not completely understood.
Diguanylyl (diguanylate) cyclases are widely spread enzymes that
combine usually a catalytic domain, related to the structure
of class III adenylyl and guanylyl cyclases, and a variety of
modules sensing the environment, or acting as regulators. The
catalytic domain contains a highly conserved pentapetide GGDEF.
The crystal structure of an example of this enzyme has shown
that the fold is similar to that of class III cyclases, but that
the nucleotide binding is somewhat differing from the situation
in its adenylyl or guanylyl cyclases counterparts.
Nucleotides play a universal role in life,
as components of nucleic acids, as forms in which chemical
free energy is stored, and as regulators of gene expression
or enzyme activity. Cyclic adenosine 3',5'-monophosphate (cAMP)
plays a universal role in the control of gene expression as
well as in the integration of metabolic functions. It is present
both in Eukarya and in Bacteria. cAMP seems to be absent only
from Archaea (but see the "adenylate cyclase" entry).
Its presence was controversial in plants, but a work investigating
opine catabolism in plants resulted in the cloning of a gene
that appeared to specify cAMP synthesis in plants. It was however
later reported that this
work was a fake, but recent data suggest that plants make
cAMP, probably via a chloroplast adenylate cyclase. Cyclic AMP
has been reported to exist in cyanobacteria and in algae. This
ubiquity explains the major interest displayed in its mode
of synthesis, and the vast amount of literature devoted to
the enzymes that produce cAMP from ATP, the adenylate cyclases
we have just described. Because cAMP is a regulatory molecule
it must be either excreted in the environment or inactivated
in order not to accumulate. This is performed by 3',5'-cyclic-nucleotide
phosphodiesterases (EC 3.1.4.17). These enzymes are generally
specific for cyclic nucleotides (namely cAMP and cGMP), and
sometimes specific for cAMP or cGMP alone. A variety of natural
inhibitors modulate their activity (nucleoside triphosphates,
pyrophosphate, and especially methylated xanthines, such as
theophylline), and by a variety of processes involving protein
phosphorylation and/or calcium. adenylate cyclases form four
independent classes of enzymes and this raises the question
of the origin of cyclic nucleotides as regulatory molecules,
as well as their universal implication in regulatory networks.
Because it is very polar, and negatively charged, cAMP does
not permeate easily into cells (unless through specific transporters,
generally poorly known at present). More lipophilic analogs
such as N6,O2'-dibutyryladenosine-3',5'monophosphate are therefore
used to modulate its concentration and mimic its effect in
cell cultures ex vivo, but in vivo inhibitors of phosphodiesterase,
or specific mediators (neuromediators in particular) are used
for therapeutic purposes where cAMP concentration must be altered.
Cyclic AMP was discovered in 1958 by E.
Sutherland, who obtained a Nobel prize in 1971 for this and
other discoveries on hormone action. As he has himself written,
it is within the scope of molecular biology that cAMP was discovered
: "When I first entered the study of hormone action,
some 25 years ago, there was a widespread feeling among biologists
that hormone action could not be studied meaningfully in the
absence of organized cell structure. However, as I reflected
upon the history of biochemistry, it seemed to me there was
a real possibility that hormones might act at the molecular
level". Sutherland built up a cell-free system where
well-known hormones could control glycolysis in vitro. Using
this system he isolated a small thermostable molecule that
was able to activate glycogen phosphorylase. Chemical analysis
of the molecule permitted its identification as adenosine 3'-5'
cyclic monophosphate. Synthesis of cAMP was shown to be the
result of the action of an enzyme, adenylate cyclase, that generated
cAMP and PPi from ATP, when activated by adrenaline. Since
this pioneering work, the study of cAMP mediated effects required
the identification of the structure, function and regulation
of adenylate cyclases, the cAMP synthesizing enzymes. And,
contrary to expectation, this did not yield a unifying picture
of the role of cAMP, but, rather, demonstrated that this molecule
has been used over and over again by living organisms for very
different functions.
At the time of cAMP discovery, the aphorism
of Jacques Monod and François Jacob, "what
is true for Escherichia coli is true for the elephant",
induced biochemists to try bacterial systems to unravel cAMP
function. After the discovery of cAMP by Sutherland in 1958,
Mackman and Sutherland demonstrated that glucose-starved Escherichia
coli cells accumulated cAMP. Ullmann and Monod later established
that part of the catabolite repression phenomenon was controlled
by cAMP. This discovery raised hopes that the study of this
mediator in Bacteria would help to understand what happens
in Eukarya (even perhaps in higher eukaryotes). However it
became soon clear that cAMP in Eukarya was generally, as found
by Sutherland, a "second messenger" that was used
as an intracellular relay molecule to the action of extracellular
hormones, while it acted directly on transcription via its
receptor, the Catabolite Activator Protein in E. coli.
Study of the slime mold Dictyostelium discoïdeum revealed
another function of cAMP, phylogenetically linked to is hormone-mediated
action in higher eukaryotes, namely a pulsatile synthesis and
degradation used by Bacteria as a signal to control their aggregation
properties as a differentiating multicellular organism.
The universal role of cAMP in controlling
such diverse metabolic processes is puzzling because adenylyl
cyclases are extremely varied, and submitted to a wide variety
of regulations. Why does this result in the synthesis of the
same molecular species, cAMP? Is not all the regulatory process
lost in this way? How can the cAMP signal generated by one
enzyme type be distinguished from another? Compartmentalization
is often invoked in this process, but while this is relatively
easily accounted for in the case of macromolecules, this is
difficult to see in the case of small molecules such as cAMP.
Another usual answer is to say that it is the combination of
hormonal receptors of differing types and cAMP — and
not cAMP alone — that is required for specificity. But
would not cAMP synthesized from different sources also be recognized?
Another answer is to remark that cAMP is known to be only one
among many second messenger : cGMP has been added to the list
as well as inositol phosphates, phosphatidyldiglycerides, calcium
etc. This certainly permits generation of a combinatorial control
of activities, but would certainly be very sensitive to accidental
synthesis of cAMP. Cyclic AMP is not synthesized in a steady-state
way (even in bacteria). It is therefore important to consider
not cAMP as such, with some average concentration, but to consider
the shape of its time-dependent variation in concentration.
In fact observations are accumulating that strongly suggest
that cAMP does not have the same effect when it is delivered
in a steady state fashion, rather than in a pulse (or a series
of pulses).
The motile and aggregating amoeba D.
discoïdeum has been used as a paradigm for cell
differentiation because undifferentiated cells start to differentiate
into specific tissues some time after starvation. Secreted
in the external medium cAMP is necessary for aggregation.
The genetics, biochemistry, cellular biology and physiology
of phenomena involving cAMP have been investigated in detail
in this organism, where it controls, as in higher eukaryotes,
a protein phosphorylation cascade, initiated after a regulatory
cAMP-binding subunit of a protein kinase detaches from its
target enzyme. This cascade is necessary not only for chemotaxis
and aggregation but also for the triggering of genes involved
in differentiation. The regulation of cAMP pulsatile concentration
is mediated by two sets of enzymes, adenylate cyclases and
phosphodiesterases. In contrast with the situation with higher
eukaryotes however, cAMP and phosphodiesterase control operates
not from the interior of the cell but from the external medium.
This requires specific membrane receptors for cAMP, and a
process of signal transduction. In D. discoïdeum the
pulses are generated by an appropriate coupling between adenylate
cyclase activity, phosphodiesterase activity and diffusion.
The main observation is that variation in the cAMP pulse
frequency changes the response of the cell. Many biochemical
models can account for such cAMP pulses. These models require
simple enzyme properties (in particular standard non linear
features, such as self-activation, and desensitization after
saturating activity). They do not require the existence of
many gene products, but only a specific behaviour of enzymes
(appropriate Vm and Km of biosynthetic and degradative enzymes).
Assuming that cAMP concentration modulation in time is the
control event is therefore not a biochemical paradox.
In Bacteria, Utsumi et al. have investigated
cyclic AMP synthesis during the cell cycle of E.coli on
synchronized cells, and they have given an unambiguous demonstration
that there was a strong correlation of cAMP synthesis and replication
or cell division, suggesting that the molecule may play some
role in the cell cycle. This is also correlated with the position
of the adenylate cyclase gene near the chromosome's origin
of replication, and with its very low level of expression,
suggesting that expression is strongly coupled to DNA replication.
This observation has long been overlooked because cells deficient
for adenylate cyclase or CAP are viable, suggesting that cAMP
is dispensable. Specific time-dependent variation of the concentration
of cAMP for fine coordination of replication and division in E.
coli is achieved by excretion of the nucleotide, rather
than coupling to the activity of a phosphodiesterase. In this
respect it is interesting that high concentrations of cAMP
produced by foreign genes in E. coli are not toxic,
till they reach a very high level (at least 10-fold the normal
concentration), whereas much lower concentration of cAMP produced
by the endogeneous adenylate cyclase are toxic. Cyclic AMP has
been formally linked to catabolite repression, but there exists
many catabolite sensitive operons that are not responding to
cAMP. In addition cAMP synthesis is very strong in E. coli when
cells enter the stationary phase of growth, suggesting that
it could be a cell to cell signal as it is in D. discoïdeum.
This may be one of its function in other bacteria (such as Rhizobium species),
where it is clearly not linked to catabolite repression.
In the same way, intracellular and extracellular
levels of cAMP vary during the cell cycle of Saccharomyces
cerevisiae. Using centrifugal elutriation, Smith et al.
showed that the intracellular cAMP concentration followed the
stages of the cell cycle, being highest during the division
cycle and lowest immediately prior or just after cell separation;
at the same time the external cAMP concentration did not vary.
Therefore, in yeast as in E. coli it appears that
the role of the external medium is to behave as a sink. These
observations substantiate the demonstration that, under normal
conditions, appropriate enzyme systems can generate a specific
time-dependent pattern of cAMP concentration. As in the case
of E. coli it is known that in S. cerevisiae adenylyl
cyclase is dispensable in mutants of the cAMP receptor, and
in S. pombe adenylate cyclase is dispensable during
vegetative growth. But, as in this former case, cells that
carry the mutation and are deficient in adenylate cyclase have
several growth defects. In this respect the function of the
time-dependent cAMP pattern could be optimisation of transient
processes, in particular cell division and chromosome segregation.
In all these cases cAMP is recognized on
the cell surface by a specific receptor. It is therefore interesting
to identify cases where membrane targets of cAMP have been
demonstrated (D. discoïdeum aside). Nerve cells
typically generate and are sensitive to transient signals,
they also have very invoved patterns of adenylate and guanylyl
cyclases regulation. In this respect it is important to observe
that cGMP (but also cAMP), has been shown to be involved as
a central molecule in vision, taste and olfaction. In particular,
in addition to their role as second messengers in protein phosphorylation
cascades, cyclic nucleotides are involved at the membrane surface,
but intracellularly, in gating ion channels in olfactory and
taste neurons. This certainly permits generation of a variety
of time-dependent patterns for cAMP regulation, as a function
of environmental inputs as well as of the fine molecular structure
of the enzyme or its subunits. Because ion channels are involved
in the main functions of neurons (firing patterns) this makes
cyclic nucleotides important in learning processes.
Indeed, many experiments have demonstrated
that cAMP is involved as a mediator of learning and memory
in invertebrates (Aplysia and Drosophila melanogaster),
as well as in vertebrates. The study of mutants of D. melanogaster that
are defective in learning and/or memory has been of major importance
in our understanding of the physiology, biochemistry, and anatomy
underlying conditioned behaviors. D. melanogaster learning
mutants have been separated into two general classes, those
with structural defects in the brain and those without obvious
brain alterations. From studies of mutants affected in the
brain structure, two areas have been found to be involved in
conditioned behavior: the mushroom bodies and the central complex.
Analysis of the mutants has shown that many types of molecules
are involved in learning, but the cAMP-mediated phosphorylation
cascade has emerged as especially important. During learning time-dependent
processes are involved in the stabilization of synapses,
a general view being that they are created during growth as
transient entities which can either regress or be stabilized.
In this process, the evolution of the synaptic pattern is dependent
on the pattern of neurotransmitter delivery. Analysis of the
minimal requirements for synapses stabilization suggests that
neurotransmitter release must be coupled to some other transient
metabolic process in a retrograde manner to yield a stable
geometry. In the cases where cAMP is involved, one can therefore
speculate that the role of this mediator is to trigger an appropriate
biochemical process, when the proper time-dependent control
of its synthesis is at work. Accordingly, once again, it
is not the cAMP concentration which is important, but, rather,
the time-variation of its concentration. In the process
of learning the regulation of adenylate cyclase activity would
therefore be exquisitely tuned to permit delivery of the molecule
in the proper time-dependent manner.
In D. melanogaster, five different
genes have proven important for normal learning: dunce (a cAMP
phosophodiesterase), rutabaga (an adenylate cyclase), amnesiac
(a product similar to adenylate cyclase activating peptides),
DCO (protein kinase A), and dCREB2 (a cAMP-response element
binding protein). The products of many of these learning mutants
are enriched in mushroom bodies. A process involving control
of transcription by the cAMP response element binding protein
(CREB)-responsive plays a central role in the formation of
long-term memory in D. melanogaster, Aplysia and
mammals. This is one of the examples where cAMP is invoved
in the control of transcription in Eukarya, as it is in Bacteria,
although through a different chain of events. Agents that prevent
CREB activity interfere with the formation of long-term memory,
whereas agents that increase the amount or activity of the
transcription factor accelerate the process, thus indicating
that CREB is essential for the switch from short-term memory
to long-term memory (protein synthesis dependent). Further
work involving inbred mice strains as well as knock-out mutants
affecting the hippocampal region demonstrated that both the
genetic background and the temporal pattern of synaptic activity
affects the cAMP-dependent synaptic plasticity.
Cyclic GMP is a structural analogue of cyclic
AMP which occurs at similar low concentration (i.e. in the
micromolar range) in many animal tissues. Its presence as a
functional molecule in Bacteria is controversial. It has been
shown to be present in E. coli, but the corresponding
intracellular concentration, in the nanomolar range, makes
it hardly a significant molecule (this would mean ca one molecule
per cell). In addition the sequence of the genome did not reveal
any polypeptide structure that could code for guanylate cyclase
in this organism. There are many reports suggesting the presence
of cGMP in Bacteria, but its presence is perhaps really likely
in myxobacteria, where it could be involved in cell aggregation
and differentiation. The recent discovery of the rather ubiquitous
presence of cyclic di-guanosine-monophosphate might account
for interference in dosage of guanylyl nucleotides. In contrast
cGMP has been demonstrated universally in Eukarya (except in
plants). It is generally involved in processes leading to activation
of specific regulation cascades, differentially controlled
by appropriate mediators, or to control specific processes
of neuronal activation of sense organs, such as the sensitivity
to light of retina receptor cells, and the triggering of olfaction
and taste. The organisation of guanylyl cyclase and control
elements is sometimes similar to — but distinct from — the
organisation of hormonally regulated adenylate cyclase. In particular
G-proteins mediated regulation of vision operates on phosphodiesterase
rather than on cyclase.
Phototransduction systems in vertebrates
and invertebrates share a great deal of similarity in overall
strategy but differ significantly in the underlying molecular
machinery. Vertebrate retinal rod cells, in the dark, synthesize
a high level of cGMP that keeps open gated sodium channels
in the plasma membrane of the outer segment. Light closes these
channels by activating an enzymatic cascade that leads to rapid
hydrolysis of cGMP by cGMP-specific phosphodiesterase. This
hyperpolarizes the cell, and modulates transmitter release
at the synaptic buttons. Photoexcited rhodopsin triggers a
transducer protein (transducin, related to G-proteins) by catalyzing
the exchange of GTP for bound GDP. Subsequently, the activated
GTP-form of transducin switches phosphodiesterase on. The cascade
(overall gain 105) is turned off by the GTPase activity
of transducin and by the action of two proteins, rhodopsin
kinase and arrestin. The kinetics of reactions in the cGMP
cascade limit the temporal resolution of the visual system,
while statistical fluctuations in the reactions limit the reliability
of detection of dim light. Together with calcium ions,and inositol
phosphates cGMP controls visual excitation and adaptation.
A light-induced fall in the internal free Ca2+ concentration
subsequently stimulates resynthesis of cGMP, antagonizes the
catalytic activity of rhodopsin, and restores the high affinity
of the light-regulated sodium channel for cGMP allowing the
cell to adapt in background light. The initial events in molluscs
and arthropods are probably similar to those of vertebrates.
However, whereas light activation of vertebrate photoreceptors
leads to activation of cGMP-phosphodiesterase and generation
of a hyperpolarizing response, activation photoreceptors of
invertebrate like Drosophila, leads to stimulation of phospholipase
C and generation of a depolarizing response. Cyclic GMP has
also been implicated in the modulation of behaviour in insects.
Cyclic GMP is also a secondary messenger
in regulation mediated by natriuretic peptide hormones, but
it is probably in the recently discovered nitric oxide (NO)
regulation cascade, that cGMP has the most unexpected role.
Nitric oxide and natriuretic peptide hormones (Atrial Natriuretic
Peptides, ANPs) play key roles in a number of neuronal functions,
including learning and memory as well as in the circulation
of blood. Most experiments suggest that they exert converging
actions by elevation of intracellular cGMP levels through activation
of soluble and membrane bound guanylyl cyclases. Cyclic GMP
is the starting point for multiple signaling cascades, which
are now beginning to be unravelled. In more than a quarter
of a century the discoveries of the existence of atrial granules
and of volume receptors in the heart atria the search for natriuretic
hormones has led to the isolation and identification of many
atrial natriuretic factors (ANF). In the heart, for example,
ANF peptides are synthesized and stored in the Golgi apparatus
of cardiac myocytes, and are released in response to atrial
wall stretch following acute plasma volume expansion and increased
central blood volume. The mechanisms of the renal action of
these potent natriuretic hormones are not yet completely unraveled.
The renal hemodynamic and tubular as well as the adrenal and
systemic vascular effects are related to enhanced cGMP synthesis
in specific medium-sized arteria, as well as in the glomeruli
and specific tubular segments, and in adrenal tissue. Specific
ANF-binding sites have been detected in these target organs.
A primary action of elevated cGMP levels is the stimulation
of cGMP-dependent protein kinase (PKG), the major intracellular
receptor protein for cGMP, which phosphorylates substrate proteins
to trigger a regulation cascade.
Cyclic GMP-dependent protein kinases also
mediate some of the neuronal effects of cGMP. Unfortunately
few PKG substrates are known in the brain. In striatonigral
nerve terminals, for example, NO mediates phosphorylation of
the protein phosphatase regulator dopamine- and cyclic AMP-regulated
phosphoprotein by PKG. It appears that PKG substrates are critically
placed in the protein phosphorylation network and regulate
protein phosphatases, intracellular calcium levels, and the
function of many ion channels and neurotransmitter receptors.
Nitric oxide acts as a signalling molecule in the nervous system
of both mammals and insects. In contrast to classical transmitters,
the NO permeates membranes, being able to act on neighbouring
targets normally limited by diffusion barriers. This diffuse
signalling is evolutionarily highly conserved. The NO forming
enzyme, NO synthase, is mostly present in the nervous system,
especially the brain. A soluble form of guanylyl cyclase, is
the major target of NO action. Usually there is cellular separation
of the release site and target site of NO, although exceptions
to this rule exist. As cAMP, cGMP seems to be important for
memory in insects : in the honeybee for exemple, the NO/cGMP
system present in the antennal lobes is implicated in the processing
of adaptive mechanisms during chemosensory processing, and
experimental data support a specific role of the NO system
in memory formation.
Signal transduction in gastric and intestinal
smooth muscle is mediated by receptors coupled via distinct
G proteins to various effector enzymes. Calcium is implicated
in signal transdcution in different ways according to the cell
type (e.g. circular and longitudinal muscle cells). The initial
steps involve Ca2+/calmodulin-dependent activation
of myosin light chain kinase and interaction of actin and myosin.
Relaxation is mediated by cAMP-and/or cGMP-dependent protein
kinase. A specific cascade involves G-protein-dependent stimulation
of Ca2+ influx leading to Ca2+/calmodulin-dependent
activation of a constitutive NO synthase in muscle cells, activating
soluble guanylyl cyclase. The resultant activation of PKA and
PKG is jointly responsible for muscle relaxation.
Cyclic GMP is therefore a secondary messenger
acting on targets that are sometimes similar to the cAMP targets,
but that proceeds through a completely different cascade, in
which the diffusible NO (and perhaps sometimes CO, which
is produced even by bacteria), plays a major role. The
nitric oxide / cyclic GMP pathway has attained public celebrity
when it was found that an inhibitor of a specific class of
cGMP phosphodiesterase, involved in the control of vasodilatation
required for penile erection could be selectively inhibited
by a fairly innocuous compound, sildenafil (UK-92,480), known
by its commercial name of the Viagra blue pill.
Go to Top
|